PG-TXL: Phase I/II

Preliminary results from 2 U.S. trials of PG-TXL showed that the product was well tolerated

Read the full 159 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE